Innovation and Translational Research Support
The Innovation and Translational Research Support Service harnesses MCHRI & Stanford’s offerings to reduce funding gaps, regulatory burden, and challenges with identifying collaborators in translational medicine.
How This Is Achieved
How We Prioritize Projects
Take referrals from MCHRI Executive Leadership and identify projects that align with SMCH Goals
Look for opportunities to partner with investigators at Project Concept, Study Design, and Pre-Award phases
Provide support for projects that do not have a direct path for patent licensure, struggle finding funding, and require industry collaboration
Services We Support
- Project Management
- Timeline Development
- Budget Building/Tracking
- Project Leadership
- Regulatory Strategy
- Target Profile Development
- Designing Paths from Bench to Bedside
- FDA/EMA Interactions
- IND/IDE Preparation and Maintenance
- Market Assessment
- Existing/Competing Solutions
- Market Sizing and Clinical Impact
- Career Development
- Team Science and Translational Medicine Faculty Development Program
- Drug & Device Development (D3) Training
- Topic Discussions
- Webinars and Live Presentations
- Funding
- Identification of funding opportunities
- Coordination with Industry & Venture Capital
- Grant writing for translational and clinical trial opportunities
Contact
Grant Wells, MS
Director of Innovation & Development
gwells2@stanford.edu